VR-ACT After Stroke: a Feasibility Study

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorUniversity of Coimbra

About this trial

This exploratory project aims to develop and pilot test, in a parallel group randomized controlled trial (RCT) design, the feasibility, acceptability, and preliminary efficacy of a self-management virtual reality (VR) 8-week program for pain management and mental health in patients with chronic post-stroke pain (CPSP), in two assessment moments (pre- to post-intervention).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

medical diagnosis of CPSP;

age between 18 and 80;

implicit de facto internet and computer literacy;

willingness to comply with the study procedures.

Disqualifiers

currently with active malignancy; -

severe cognitive impairment;

currently undergoing any psychological intervention or VR-delivered pain management program;

current severe psychiatric symptoms (i.e., psychosis; severe depression; non-suicidal self-injury; suicide attempt in the last month);

Trial design

Design model

Parallel

Treatments tested in this trial

  • VR-ACT

    Behavioral

    8 MODULES OF 3D VIRTUAL REALITY Modules 1 \& 2: Awareness Regulation Skills Modules 3, 4 \& 5: Acceptance of Pain and Internal Experiences Modules 6, 7 \& 8: Behavior Change and Valued Action

  • Sham-VR

    Behavioral

    8 2D non-immersive distracting video-animations delivered through a VR headset.

Treatment groups

30 Participants
are divided into 2 treatment groups
Group A: VR-ACTExperimental treatment 1 intervention
Group B: Sham-VRSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Pain intensity

\- The Numeric Rating Scale (NRS)

Time frame
From enrollment to the end of treatment at 8 weeks
2

Pain Impact

\- Pain Disability Index (PDI)

Time frame
From enrollment to the end of treatment at 8 weeks
3

Mental Health

Mental Health: \- Depression Anxiety and Stress Scale (DASS-21)

Time frame
From enrollment to the end of treatment at 8 weeks
4

Psychological and Physical Quality of Life

\- World Health Organization Quality of Life - Bref (WHOQOL- Bref)

Time frame
From enrollment to the end of treatment at 8 weeks

Secondary outcomes

1

Mindful Awareness

Mindful Awareness: \- Mindful Attention Awareness Scale (MAAS)

Time frame
From enrollment to the end of treatment at 8 weeks
2

Emotional Regulation

Emotional Regulation: \- Difficulties in Emotion Regulation Scale - Short Form (DERS-SF)

Time frame
From enrollment to the end of treatment at 8 weeks
3

Psychological Flexibility

Psychological Flexibility: \- Comprehensive Assessment of Acceptance and Commitment Therapy Processes (CompACT)

Time frame
From enrollment to the end of treatment at 8 weeks

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Coimbra

Lead sponsor

Unidade Local de Saúde de Coimbra, EPE

Collaborator

This trial is not recruiting at the moment. You can still explore other options: